Stay updated on Indoximod Combo in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Indoximod Combo in Melanoma Clinical Trial page.

Latest updates to the Indoximod Combo in Melanoma Clinical Trial page
- Check5 days agoChange DetectedThe page now shows related topics for Melanoma and MedlinePlus Genetics, linking the study to the disease context and a genetics information resource.SummaryDifference0.2%

- Check13 days agoChange DetectedThe Melanoma condition label appears to be removed from the study page, along with the related topics header and the MedlinePlus Genetics reference. This reduces disease-specific context and access to related resources for readers.SummaryDifference0.2%

- Check20 days agoChange DetectedThe page revision string was updated from v3.5.3 to v3.5.4, indicating a new, minor version of the page. This appears to be an administrative update rather than a change to study content or functionality.SummaryDifference0.1%

- Check27 days agoChange DetectedNo additions or deletions were reported; the page content remains unchanged according to the provided changes data.SummaryDifference0.1%

- Check34 days agoChange DetectedMelanoma is added under the MedlinePlus Genetics related topics section, and MedlinePlus Genetics is listed as a related topic on the page. This update provides an additional consumer health information resource connected to the study.SummaryDifference0.2%

- Check42 days agoChange DetectedThe page footer has been updated to reflect a newer ClinicalTrials.gov software/release revision (moving from v3.5.2 to v3.5.3).SummaryDifference0.1%

Stay in the know with updates to Indoximod Combo in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Indoximod Combo in Melanoma Clinical Trial page.